Concepedia

Kenneth Saunders

KS

10

Publications

374

Citations

10

H-Index

1994

Active since

Affiliations

Pfizer (United Kingdom)(Current)

UCB Pharma (Belgium)

Pfizer (United States)

Molecular Partners (Switzerland)

University of Aberdeen

Kenneth Saunders is an author at Pfizer (United Kingdom) specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

1994–2021

10

Publications

10

Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain

Mischa Müller, Kenneth Saunders, Christopher Grace et al. · mAbs · 2012 · 86 citations · Full text

, , +13

An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC–MS/MS end-point

Kuresh Youdim, Richard Lyons, Leon Payne et al. · Journal of Pharmaceutical and Biomedical Analysis · 2008 · 60 citations

, , +8

pH-Mediated field-amplified sample stacking of pharmaceutical cations in high-ionic strength samples

David J. Weiss, Kenneth Saunders, Craig E. Lunte · Electrophoresis · 2001 · 53 citations

In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development

John Steven, Mischa Müller, Miguel F. Carvalho et al. · Frontiers in Immunology · 2017 · 44 citations · Full text

Automation and robotics in ADME screening

Kenneth Saunders · Drug Discovery Today Technologies · 2004 · 43 citations

, , +8

Rows per page

1–5 of 10